These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2389438)

  • 1. Pharmacokinetics of cyclosporine A in bilateral lung transplantation candidates with cystic fibrosis.
    Mancel-Grosso V; Bertault-Peres P; Barthelemy A; Chazalette JP; Durand A; Noirclerc M
    Transplant Proc; 1990 Aug; 22(4):1706-7. PubMed ID: 2389438
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine bioavailability in heart-lung transplant candidates with cystic fibrosis.
    Cooney GF; Fiel SB; Shaw LM; Cavarocchi NC
    Transplantation; 1990 Apr; 49(4):821-3. PubMed ID: 2326880
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine-related neurotoxicity in a patient after bilateral lung transplantation for cystic fibrosis.
    Lischke R; Simonek J; Stolz AJ; Schützner J; Belsan T; Marusic P; Pafko P
    Transplant Proc; 2004 Nov; 36(9):2837-9. PubMed ID: 15621163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung transplantation for cystic fibrosis: 6-year follow-up.
    Quattrucci S; Rolla M; Cimino G; Bertasi S; Cingolani S; Scalercio F; Venuta F; Midulla F
    J Cyst Fibros; 2005 May; 4(2):107-14. PubMed ID: 15914093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diltiazem improves cyclosporine dosage in cystic fibrosis lung transplant recipients.
    Shennib H; Auger JL
    J Heart Lung Transplant; 1994; 13(2):292-6. PubMed ID: 8031814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine monitoring with polyclonal and specific monoclonal antibodies during episodes of renal allograft dysfunction.
    Holt DW; Marsden JT; Johnston A; Taube DH
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1482-4. PubMed ID: 2652475
    [No Abstract]   [Full Text] [Related]  

  • 7. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
    Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-cell lung carcinoma of recipient origin after bilateral lung transplantation for cystic fibrosis.
    Picard C; Grenet D; Copie-Bergman C; Martin N; Longchampt E; Zemoura L; Stern M
    J Heart Lung Transplant; 2006 Aug; 25(8):981-4. PubMed ID: 16890121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined islet-lung transplantation in a cystic fibrosis patient.
    Bühler L; Andereggen E; Deng S; Spiliopoulos A; Nicod L; Rochat T; Tschopp JM; Cretin N; Fournier B; Conrad B; Mentha G; Morel P
    Schweiz Med Wochenschr Suppl; 1996; 79():73S-75S. PubMed ID: 8701266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic profile and variability of cyclosporine versus neoral in patients with cystic fibrosis after lung transplantation.
    Kesten S; Scavuzzo M; Chaparro C; Szalai JP
    Pharmacotherapy; 1998; 18(4):847-50. PubMed ID: 9692659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lung transplantation and the development of diabetes mellitus in adult patients with cystic fibrosis].
    Navas de Solís MS; Merino Torres JF; Mascarell Martínez I; Piñón Sellés F
    Arch Bronconeumol; 2007 Feb; 43(2):86-91. PubMed ID: 17288897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine pharmacokinetics in a lung transplant patient undergoing hemofiltration.
    Cleary JD; Davis G; Raju S
    Transplantation; 1989 Oct; 48(4):710-2. PubMed ID: 2799932
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine dosing in cystic fibrosis after transplantation.
    Scott JP; Smyth RL; Higenbottam TW; McGoldrick JP; Wallwork J
    Transplantation; 1989 Sep; 48(3):543-4. PubMed ID: 2675421
    [No Abstract]   [Full Text] [Related]  

  • 14. Cystic fibrosis and lung transplantation: ethical concerns.
    Dickinson-Herbst D
    Pediatr Nurs; 2001; 27(1):87-9. PubMed ID: 12025156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lung transplantation in cystic fibrosis--a position paper].
    Gottlieb J; Ballmann M; von Mallinckrodt C; Staab D; Smaczny C; Simon A; Welte T; Wagner TO
    Pneumologie; 2009 Aug; 63(8):451-60. PubMed ID: 19670104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful lung transplantation in spite of cystic fibrosis-associated liver disease: a case series.
    Klima LD; Kowdley KV; Lewis SL; Wood DE; Aitken ML
    J Heart Lung Transplant; 1997 Sep; 16(9):934-8. PubMed ID: 9322144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of cyclosporine in heart and lung transplant candidates and recipients with cystic fibrosis and Eisenmenger's syndrome.
    Tan KK; Trull AK; Hue KL; Best NG; Wallwork J; Higenbottam TW
    Clin Pharmacol Ther; 1993 May; 53(5):544-54. PubMed ID: 8491066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung transplantation for cystic fibrosis.
    Coloni GF; Venuta F; Ciccone AM; Rendina EA; De Giacomo T; Filice MJ; Diso D; Anile M; Andreetti C; Aratari MT; Mercadante E; Moretti M; Ibrahim M
    Transplant Proc; 2004 Apr; 36(3):648-50. PubMed ID: 15110621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sandimmun neoral improves the bioavailability of cyclosporin A and decreases inter-individual variations in patients affected with cystic fibrosis.
    Girault D; Haloun A; Viard L; Bellon G; Gottrand F; Guillemain R; Lenoir G; Ladurie FL; Plouvier E; Storni V
    Transplant Proc; 1995 Aug; 27(4):2488-90. PubMed ID: 7652899
    [No Abstract]   [Full Text] [Related]  

  • 20. Specific and nonspecific monoclonal 125I-Incstar assays.
    Wong PY; Ma J
    Transplant Proc; 1990 Jun; 22(3):1166-70. PubMed ID: 2349680
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.